AstraZeneca PLC (AZNCF)
OTCMKTS · Delayed Price · Currency is USD
169.00
+3.74 (2.26%)
Nov 6, 2025, 11:32 AM EST
AstraZeneca Market Cap
AstraZeneca has a market cap or net worth of $251.76 billion as of November 6, 2025. Its market cap has increased by 7.78% in one year.
Market Cap
251.76B
Enterprise Value
276.44B
Revenue
58.13B
Ranking
n/a
PE Ratio
26.79
Stock Price
$169.00
Market Cap Chart
Since May 28, 1993, AstraZeneca's market cap has increased from 7.10B to 251.76B, an increase of 3,445.50%. That is a compound annual growth rate of 11.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 251.76B | 23.92% |
| Dec 31, 2024 | 203.17B | -2.91% |
| Dec 29, 2023 | 209.27B | -0.08% |
| Dec 30, 2022 | 209.44B | 15.06% |
| Dec 31, 2021 | 182.03B | 38.68% |
| Dec 31, 2020 | 131.26B | -0.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 654.92M |
| Glass House Brands | 582.61M |
| Northwest Biotherapeutics | 386.96M |
| Nika Pharmaceuticals | 311.89M |
| CytoDyn | 311.61M |
| Silence Therapeutics | 307.49M |
| American Oncology Network | 307.04M |